Viral Hepatitis Prevention and Control

Objective

Program activities support integrated viral hepatitis surveillance and prevention programs in states and large cities in the United States. Key strategies include viral hepatitis outbreak planning and response; and surveillance for acute hepatitis A, B and C, and chronic hepatitis C. Partners should develop a jurisdictional viral hepatitis elimination plan, increase comprehensive hepatitis B and C reporting, improve HBV and HCV testing and increase healthcare providers trained to treat hepatitis B and C. Contingent on funding, the following activities can be supported: surveillance for chronic hepatitis B and perinatal hepatitis C; increased hepatitis B and C testing and referral to care in high-impact settings (syringe services programs (SSPs), substance use disorder (SUD) treatment centers, correctional facilities, emergency departments and sexually transmitted disease clinics; and increased access to services preventing viral hepatitis and other infections among persons who inject drugs (PWID). Contingent on funding, an optional component will support improved access to prevention, diagnosis, and treatment of viral, bacterial and fungal infections related to drug use in settings disproportionately affected by drug use. Expected outcomes include improved surveillance for viral hepatitis, increased stakeholder engagement in viral hepatitis elimination planning, and improved access to viral hepatitis prevention, diagnosis, and treatment among populations most at risk.

Who Can Apply

• U.S. State Government (including the District of Columbia)
• U.S. Territory (or Possession) Government (including freely-associated states)
• Federally Recognized Indian/Native American/Alaska Native Tribal Government
• Indian/Native American/Alaska Native Tribal Government (Other than Federally Recognized)
• Tribally Designated Housing Authority
• County Government (inclusive of boroughs in Alaska, parishes and other governmental entities with geographic regional control and authority)
• Interstate Organization
• Municipality or Township government (inclusive of cities, towns, boroughs (except in Alaska), and villages)
• School District Government
• School District
• Local
• Other Special Disctrict Government
• State
• Territorial
• Tribal
• Nonprofit Organization
• For-Profit Organization

Dependent upon the individual NOFO, eligibility may range from open competition, limited competition, single-source, domestic and/or international in accordance with the authorizing legislation.

Who Benefits

• Individual/Family
• Anyone/general public
• State
• Local
• Public nonprofit institution/organization
• Federally Recognized Indian Tribal Governments

The general public will benefit from the objectives of this program as well society from the savings realized from treating those that are infected with viral hepatitis.

Assistance Types

• Cooperative Agreement

Program Contact

gpo4@cdc.gov
4046398432